Ionian Technologies signs agreement with Roche Diagnostics
RHHZY | Quote | Chart | News | PowerRating -- Ionian Technologies, Inc., a biotechnology company, has signed an agreement with Roche Diagnostics Corp., a division of Roche Holding, Ltd. Both Ionian and Roche Diagnostics are based in the US.
Under the terms of the agreement, Roche Diagnostics will identify new applications and customers for Ionian's isothermal nucleic acid amplification technology and will bring these opportunities to Ionian.. Roche Diagnostics will have exclusive manufacturing rights for these specific opportunities upon commercialization.
NEAR Assay(TM), Ionian's isothermal amplification technology, is used for the detection of both DNA and RNA from bacterial or viral pathogens.
Deal Type Partnership
Sub-Category Commercialization
Deal Status Announced: 2009-11-12
Deal Participants
Partner 1 (Company) Ionian Technologies, Inc.
Partner 2 (Company) Roche Diagnostics Corp.
Partner 3 (Company) Roche Holding, Ltd.
For full details on (RHHZY) RHHZY. (RHHZY) has Short Term PowerRatings at TradingMarkets. Details on (RHHZY) Short Term PowerRatings is available at This Link.
- b3 bio signs development collaboration with Roche - 01/22/10
- Galapagos signs agreeement with Roche for chronic obstructive pulmonary disease - 01/11/10
- Weird Science? Big Pharma's Top Three M&A Deals in 2009 Nears $160 Billion, an Industrial Info News Alert - 01/11/10
- Ionian Technologies signs agreement with Roche Diagnostics - 11/12/09
- Alnylam Pharmaceuticals signs co-development agreement with Roche for RNAi therapeutics - 11/05/09
- More News >>


